A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis
Clinical trial NCT02473952 · COMPLETED
Trial details
- NCT number
- NCT02473952
- Sponsor
- Grifols Therapeutics LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2018-01-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.